logo
Plus   Neg
Share
Email

Daimler AG Extends Management Board Appointments For Truck CEO Martin Daum, CFO Harald Wilhelm

German automaker Daimler AG (DDAIF.PK) Friday announced that its Supervisory Board at its meeting extended the appointments of management board members Martin Daum and Harald Wilhelm .

The appointment of Daum, 61,, as member of the board of management for Daimler AG and Chief Executive of Daimler Truck AG, was extended until 2025.

Further, the appointment of Wilhelm, 55, management board member of Daimler AG, and responsible for Finance, Controlling and Daimler Mobility, was extended until 2027.

Daum has been a management board member since 2017 after serving as President and CEO of Daimler Trucks North America. Following the planned spin-off of a majority stake in Daimler Truck AG, Daum plans to leave Daimler AG and to take on the role of Chief Executive Officer at stock market listed Daimler Truck company.

Wilhelm has been in the board since 2019 and was previously Chief Financial Officer of the Airbus Group. Wilhelm's appointment as management board member responsible for Finance and Controlling at Mercedes-Benz AG was also extended.

Further, Joe Kaeser was on Thursday appointed to the supervisory board of Daimler Truck AG. He will be proposed as the candidate for chairman of the supervisory board of Daimler Truck.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fashion retailer L Brands, Inc. announced Tuesday that its Board of Directors has unanimously approved a plan to separate the company into two independent publicly traded companies. The two public companies will be Bath & Body Works, one of the world's leading bath, body and home fragrance retailers, and Victoria's Secret, including Victoria's Secret Lingerie, PINK and Victoria's Secret Beauty. Danish pharmaceutical company Novo Nordisk A/S is recalling 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy to the consumer level, due to improper storage temperature conditions, the U.S. Food and Drug Administration said. The Food and Drug Administration on Monday expanded the emergency use authorization of Pfizer-BioNTech's Covid-19 vaccine to include 12- to 15-year-olds. "The FDA's expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age...
Follow RTT